X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XFOR X4制药

已收盘 07-05 16:00:00 EDT

0.5489

-0.0156

-2.76%

盘后0.5491

+0.0002+0.04%

19:59 EDT

最高0.5788	最低0.5369	成交量219.69万
今开0.5788	昨收0.5645	日振幅7.42%
总市值9,218万	流通市值7,018万	总股本1.68亿
成交额120.46万	换手率1.72%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4制药","latestPrice":0.5489,"timestamp":1720209600000,"preClose":0.5645,"halted":0,"volume":2196869,"hourTrading":{"tag":"盘后","latestPrice":0.5491,"preClose":0.5489,"latestTime":"19:59 EDT","volume":27014,"amount":14836.196699,"timestamp":1720223995786},"delay":0,"floatShares":127863544,"shares":167937781,"eps":-0.673813,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0156,"latestTime":"07-05 16:00:00 EDT","open":0.5788,"high":0.5788,"low":0.5369,"amount":1204612.60588564,"amplitude":0.074225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.673813,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720425600000},"adr":0,"listingDate":1510808400000,"adjPreClose":0.5645,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.5777,"preClose":0.5645,"latestTime":"09:23 EDT","volume":18189,"amount":10448.720160300001,"timestamp":1720185814325},"postHourTrading":{"tag":"盘后","latestPrice":0.5491,"preClose":0.5489,"latestTime":"19:59 EDT","volume":27014,"amount":14836.196699,"timestamp":1720223995786},"volumeRatio":0.258647,"impliedVol":1.5175,"impliedVolPercentile":0.4762},"requestUrl":"/m/hq/s/XFOR","defaultTab":"news","newsList":[{"id":"2448485906","title":"X4制药盘中异动 股价大涨5.05%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448485906","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448485906?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:41","pubTimestamp":1720014108,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时41分，X4制药股票出现异动，股价快速上涨5.05%。截至发稿，该股报0.572美元/股，成交量16.0949万股，换手率0.10%，振幅1.80%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-0.85倍。X4制药股票所在的生物技术行业中，整体跌幅为0.21%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214148af9065c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214148af9065c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2448415036","title":"X4制药盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448415036","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448415036?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:16","pubTimestamp":1719929788,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时16分，X4制药股票出现异动，股价大幅下跌5.04%。截至发稿，该股报0.560美元/股，成交量46.793万股，换手率0.28%，振幅4.63%。X4制药股票所在的生物技术行业中，整体跌幅为1.16%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070222162896818d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070222162896818d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2448716918","title":"X4制药盘中异动 股价大涨5.28%报0.611美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448716918","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448716918?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840661,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，X4制药股票出现波动，股价快速拉升5.28%。截至发稿，该股报0.611美元/股，成交量10.8542万股，换手率0.06%，振幅0.26%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.05%。消息层面，截至21时31分，《H.C. Wainwright维持X4制药买入评级，维持目标价5美元》资讯为影响X4制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131019eed388a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131019eed388a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2446238553","title":"X4制药盘中异动 早盘快速跳水15.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446238553","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446238553?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:32","pubTimestamp":1719495121,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时32分，X4制药股票出现波动，股价快速下跌15.99%。截至发稿，该股报0.840美元/股，成交量126.439万股，换手率0.75%，振幅5.60%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272132019f6c16b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272132019f6c16b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2446929433","title":"X4制药盘中异动 股价大涨5.20%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446929433","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446929433?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:36","pubTimestamp":1719412619,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时36分，X4制药股票出现波动，股价快速拉升5.20%。截至发稿，该股报1.010美元/股，成交量19.4332万股，换手率0.12%，振幅4.25%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-1.49倍。X4制药股票所在的生物技术行业中，整体跌幅为0.89%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223659941f16c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223659941f16c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2446009873","title":"X4制药盘中异动 急速下挫5.03%报0.959美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446009873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446009873?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:24","pubTimestamp":1719343471,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时24分，X4制药股票出现波动，股价急速下跌5.03%。截至发稿，该股报0.959美元/股，成交量121.74万股，换手率0.72%，振幅6.93%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为1.82%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626032431af8f2489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626032431af8f2489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2445996897","title":"X4制药盘中异动 急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445996897","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445996897?lang=zh_cn&edition=full","pubTime":"2024-06-22 02:57","pubTimestamp":1718996279,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日02时57分，X4制药股票出现异动，股价急速上涨5.21%。截至发稿，该股报1.010美元/股，成交量83.4076万股，换手率0.50%，振幅5.56%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.18%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622025759af8eaaad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622025759af8eaaad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2444116797","title":"X4制药盘中异动 临近收盘快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116797","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116797?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:43","pubTimestamp":1718653422,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日03时43分，X4制药股票出现异动，股价大幅跳水5.11%。截至发稿，该股报0.968美元/股，成交量99.2824万股，换手率0.59%，振幅6.21%。X4制药股票所在的生物技术行业中，整体涨幅为0.14%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061803434296814b01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061803434296814b01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2443725605","title":"X4制药盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443725605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443725605?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:30","pubTimestamp":1718386226,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时30分，X4制药股票出现波动，股价大幅下跌5.19%。截至发稿，该股报1.01美元/股，成交量35.2725万股，换手率0.21%，振幅2.83%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013026af8da65e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013026af8da65e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2443687178","title":"X4制药盘中异动 股价大跌5.41%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443687178","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443687178?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:52","pubTimestamp":1718290362,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时52分，X4制药股票出现异动，股价大幅跳水5.41%。截至发稿，该股报1.05美元/股，成交量55.7536万股，换手率0.33%，振幅7.21%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.34%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613225242941ee653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613225242941ee653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2441710708","title":"X4制药盘中异动 早盘快速跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441710708","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441710708?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:57","pubTimestamp":1717682277,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时57分，X4制药股票出现异动，股价急速下挫5.09%。截至发稿，该股报1.03美元/股，成交量14.6292万股，换手率0.09%，振幅3.15%。X4制药股票所在的生物技术行业中，整体涨幅为0.85%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606215758aef3d1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606215758aef3d1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2441209683","title":"X4制药盘中异动 大幅下跌5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441209683","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441209683?lang=zh_cn&edition=full","pubTime":"2024-06-06 00:59","pubTimestamp":1717606744,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日00时59分，X4制药股票出现异动，股价快速下挫5.56%。截至发稿，该股报1.02美元/股，成交量78.1861万股，换手率0.47%，振幅6.49%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为1.30%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606005905af8c2cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606005905af8c2cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2440945247","title":"X4制药盘中异动 下午盘股价大涨5.54%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440945247","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440945247?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:56","pubTimestamp":1717178193,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时56分，X4制药股票出现异动，股价急速拉升5.54%。截至发稿，该股报1.030美元/股，成交量38.0771万股，换手率0.23%，振幅5.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-1.52倍。X4制药股票所在的生物技术行业中，整体涨幅为0.39%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015633aef2d1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601015633aef2d1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2438309778","title":"X4制药盘中异动 股价大涨5.17%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438309778","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438309778?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:12","pubTimestamp":1716909171,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日23时12分，X4制药股票出现波动，股价快速拉升5.17%。截至发稿，该股报0.950美元/股，成交量24.1128万股，换手率0.14%，振幅2.23%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-1.40倍。X4制药股票所在的生物技术行业中，整体跌幅为1.70%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528231251af8ab637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528231251af8ab637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2437291405","title":"X4制药盘中异动 急速拉升5.36%报0.945美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437291405","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437291405?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:32","pubTimestamp":1716388360,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时32分，X4制药股票出现波动，股价大幅上涨5.36%。截至发稿，该股报0.945美元/股，成交量14.3037万股，换手率0.09%，振幅6.49%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.20%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522223241941e9751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522223241941e9751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2435065873","title":"X4制药盘中异动 快速下挫5.71%报0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435065873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435065873?lang=zh_cn&edition=full","pubTime":"2024-05-14 02:05","pubTimestamp":1715623531,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日02时05分，X4制药股票出现异动，股价大幅下跌5.71%。截至发稿，该股报0.990美元/股，成交量202.732万股，换手率1.21%，振幅7.09%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为1.18%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514020531792764d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514020531792764d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2435370723","title":"X4制药2024财年第一财季实现净利润-51.77百万美元，同比减少115.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435370723","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435370723?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:23","pubTimestamp":1715617413,"startTime":"0","endTime":"0","summary":"3月31日，X4制药公布财报，公告显示公司2024财年第一财季净利润为-51.77百万美元，同比减少115.53%；其中营业收入为0.00美元，每股基本收益为-0.26美元。从资产负债表来看，X4制药总负债1.11亿美元，其中短期债务1.13百万美元，资产负债比为1.01，流动比率为3.71。机构评级：截至2024年3月31日，当前有7家机构对X4制药目标价做出预测，其中目标均价为4.12美元，其中最低目标价为1.00美元，最高目标价为5.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140023458b0271e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140023458b0271e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR"],"gpt_icon":0},{"id":"2434253852","title":"X4制药盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434253852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434253852?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:57","pubTimestamp":1715349469,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时57分，X4制药股票出现异动，股价大幅拉升5.16%。截至发稿，该股报1.12美元/股，成交量50.8308万股，换手率0.30%，振幅6.05%。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.37%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510215749861ec711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510215749861ec711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2434577770","title":"X4制药盘中异动 大幅跳水5.05%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434577770","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434577770?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:10","pubTimestamp":1715195421,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日03时10分，X4制药股票出现异动，股价快速跳水5.05%。截至发稿，该股报1.04美元/股，成交量111.531万股，换手率0.66%，振幅3.67%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.58%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090310227a58c7dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405090310227a58c7dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.x4pharma.com","stockEarnings":[{"period":"1week","weight":-0.4355},{"period":"1month","weight":-0.4355},{"period":"3month","weight":-0.616},{"period":"6month","weight":-0.2854},{"period":"1year","weight":-0.6997},{"period":"ytd","weight":-0.3268}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0448},{"period":"3month","weight":0.0748},{"period":"6month","weight":0.1785},{"period":"1year","weight":0.2426},{"period":"ytd","weight":0.1602}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司，发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法，重点关注免疫系统功能障碍导致的疾病。公司主导临床候选药物为mavorixafor，一种趋化因子受体CXCR4的小分子选择性拮抗剂。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员，他们认为mavorixafor有可能在多种慢性中性粒细胞减少性疾病中提供治疗益处，包括WHIM综合征，这是一种罕见的原发性免疫缺陷。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.003431},{"month":2,"riseRate":0.714286,"avgChangeRate":0.081966},{"month":3,"riseRate":0.571429,"avgChangeRate":0.137927},{"month":4,"riseRate":0.285714,"avgChangeRate":0.026234},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.016456},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.244326},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.087046},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.084948},{"month":9,"riseRate":0.333333,"avgChangeRate":0.020336},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.100121},{"month":11,"riseRate":0.333333,"avgChangeRate":0.267309},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.202177}],"exchange":"NASDAQ","name":"X4制药","nameEN":"X4 Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"X4制药,XFOR,X4制药股票,X4制药股票老虎,X4制药股票老虎国际,X4制药行情,X4制药股票行情,X4制药股价,X4制药股市,X4制药股票价格,X4制药股票交易,X4制药股票购买,X4制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}